Arcellx Inc - ACLX Company Long-Term Liabilities

Arcellx Inc - graphic logo of issuer ACLX

Arcellx is upgrading its cell therapy manufacturing equipment, which is driving share price growth. An analysis of the company's long-term debt confirms its financial stability, and the value of 0.04 characterizes this level. The strategy relies on outsourcing clinical trials through CRO partners and implementing ESG environmental standards for biohazardous waste disposal in laboratories.

ACLX (arcellx.com) Company Long-Term Debt history from 04/28/2023 to 05/09/2026

Summary analytical data breakdowns for Arcellx Corp (ACLX)

- price and consensus price forecast:
Share Price arcellx.com|ACLX - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Arcellx|ACLX - Enterprise Value
- book capitalization data:
Net Asset Value per Share Arcellx|ACLX - Company Book Value|Market Value to Book Value arcellx.com|ACLX - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Arcellx|ACLX - Long-Term Debt to Capital|Short-Term Debt to Equity Arcellx Therapeutics|ACLX - Company Debts|Debt to Book Capitalization Ratio Arcellx|ACLX - Company Long-Term Debt|Short-Term Debt Arcellx
Analysis of all company metrics:arcellx.com (ACLX)
Original product of Arcellx Therapeutics

When screening issuer reliability, the long-term debt volume of Arcellx serves as an indicator of total credit and bond obligations with maturities exceeding one year, reflecting the business's long-term debt burden. For Arcellx, this metric is critical, as the absence of current sales due to the drug testing stage makes the company dependent on external financing until the potential of big pharma partnerships is realized.

Direct competitors

Company Long-Term Indebtedness tgtherapeutics.com TGTX|IRON: Company Long-Term Debts|SNDX - Company Long-Term Liabilities|Company Long-Term Debts KURA|ADCT (ADC Pharma) - Long-Term Debt|FHTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings vorbio.com (VOR)|Nkarta, Inc. (NKTX) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings coeptistx.com (COEP)|Company Long-Term Debts Actinium Pharmaceuticals Inc ATNM|Estrella Immunopharma Corp - Company Long-Term Debt|CASI - Company Long-Term Debt|MRKR: Company Long-Term Debt|Company Long-Term Debt INAB|ERNA (Eterna Therapeutics Inc.) - Long-Term Debt|Company Long-Term Debt GTBP (GT Biopharma Corp)|Long-Term Debt Aptose|Company Long-Term Debts Bio-Path Holdings BPTH|Company Long-Term Indebtedness meipharma.com (MEIP)|Company Long-Term Debts VINC (Vincerx Pharma)